Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Trabeculectomy With Mitomycin C Associated With Sub-conjunctival Injection of Ranibizumab

This study has been completed.
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
Gisele Li, Maisonneuve-Rosemont Hospital
ClinicalTrials.gov Identifier:
NCT00892398
First received: May 1, 2009
Last updated: April 8, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2014
  Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)